Stockreport

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

Reviva Pharmaceuticals Holdings, Inc.  (RVPH) 
PDF CUPERTINO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical comp [Read more]